Category

News

Press release: Nico.lab to Australian stock exchange and North America

By | News, Press Release

Amsterdam, August 27th 2018 – The Dutch healthtech company Nico.lab prepares for an IPO in Australia after the company has previously collected 3 million euros from Australian investors. In addition, Nico.lab will enter the US market. Nico.lab is the result of a collaboration between Amsterdam UMC and health tech venture builder NLC. With years of intensive clinical research in the Amsterdam UMC, the company has developed StrokeViewer®, a software product that significantly speeds up the diagnosis and treatment of strokes. Nico.lab now focuses on making StrokeViewer based on artificial intelligence (AI) available to more and more patients.

In the treatment of stroke, speed is crucial to limit the brain damage for the patient as much as possible; a patient quickly loses 27 healthy days of life per minute of treatment delay. Using AI, Nico.lab software analyzes brain scans to recognize and accurately assess stroke indicators. This all happens in a few minutes and thus considerably increases the chance of a positive result for the patient. In addition, the algorithm contains self-learning ability, and provides additional knowledge about this common disease and the functioning of the brain in such a serious situation.

This year, StrokeViewer is tested among 3,000 patients in various hospitals in the Netherlands and compared with the current method that has been used for years to diagnose a stroke. In other countries, the results achieved with StrokeViewer did not go unnoticed and Nico.lab recently won a European prize of half a million euros. The company has also been asked to participate in clinical trials in North America and Australia.

In order to meet the growing demands for StrokeViewer, new investments are necessary. The large Australian investment interest has resulted in Nico.lab attracting 3 million euros in investments from various investors. The investment round is part of an IPO in Australia. The IPO of Nico.lab is planned for early 2019. In addition to interest from Australia, there has also been interest from North America. Tech giants, including Google, Intel and HP have entered into a partnership with Nico.lab to prepare for the introduction of StrokeViewer on the US market in early 2019.

Merel Boers, Chief Research Officer at Nico.lab: “We are very pleased with the great interest in our product that combines the latest clinical research results with state-of-the-art AI technology. This movement shows that an impact can be made in health care. We want to work hard on further expanding StrokeViewer in the coming years to help more patients. ”

About Nico.lab

Nico.lab’s StrokeViewer uses Artificial Intelligence to shorten the time of determining the appropriate treatment for strokes to a few minutes, where it can sometimes take hours under the current method. StrokeViewer is now being rolled out in several Dutch hospitals. Nico.lab is the result of a collaboration between Amsterdam UMC and health tech venture builder NLC.

For more information please contact:
020 244 0852 / info@nico-lab.com

Nico.lab welcomes the new European General Data Protection Regulation (GDPR)

By | News

On May the 25th, the new General Data Protection Regulation (GDPR) comes into effect in the European Union. With the GDPR, the EU aims to protect the privacy and personal data of all citizens. The GDPR gives every individual primary control over his/her data, and holds all companies and organizations accountable for safe and legitimate processing of this data.

The GDPR has an important impact on the collection and processing of medical data. As a processor of sensitive medical data, Nico.lab welcomes and emphasizes compliance with the GDPR. Nico.lab incorporates security of StrokeViewer as one of its core values in the development of StrokeViewer, making StrokeViewer secure-by-design. Also, StrokeViewer only shows the necessary information for diagnostic purposes “by default”, and can be tailored per hospital. To ensure the utmost quality of our company Infomation Security Management System (ISMS), Nico.lab is supported by fore-front legal offices specialized in medical technology.

We are happy to answer any questions regarding privacy and security. Please send a message via our contact page. For further information regarding the GDPR, please read the information provided by the EU.

Visit Nico.lab at the European Stroke Organization Conference (ESOC) 2018

By | News

Nico.lab will be present at this year’s European Stroke Organization Conference (ESOC), held in Gothenburg, Sweden from May 16th-18th. The ESOC is one of the world’s leading conference on stroke, enabling learning, discussion, and exchange among European and international stroke specialists. Guided by the motto “The Voice of Stroke in Europe,” the Conference focuses about the latest clinical trials and developments in all areas of stroke management, treatment and prevention.  Visit us in the Exhibition hall at Booth 32b for a demo.

Press Release: Better treatment of stroke using artificial intelligence and blockchain

By | News, Press Release

Amsterdam, 21th March 2018  Every year about 50,000 people in the Netherlands are affected by a stroke. About 10,000 of these patients die and this number continues to increase. In order to reduce mortality, it is crucial to start the right treatment as soon as possible. Innovative technologies such as artificial intelligence and blockchain can help improve the outcome of a stroke.

For this purpose, Nico.lab, a spin-off of the Academisch Medisch Centrum (AMC) and developer of medical artificial intelligence, in collaboration with Tymlez, a provider of enterprise blockchain technology, have joined forces. Both companies are starting a pilot this month with a number of hospitals for superior treatment of strokes. They received funding from the Ministry of Economic Affairs and climate, which underlines the importance of these innovations.

Stroke is the leading cause of death after heart diseases and cancer in our country.

Rapid treatment crucial
Every hour that doctors are going to treat earlier, the number of patients who will recover without major problems increases by 15%. This means not only a significant improvement in the quality of life, but also a decrease in the economic cost of stroke. These amounts are currently more than EUR 1.7 billion per annum for the Netherlands.

A doctor can only choose the right treatment if there is a lot known about the problem in the patient’s brain, as with an infarction, the exact location of any blood clot. Viewing the scans by a doctor is however complex and time-consuming. Moreover, in practice, the analysis of the brain scan does not always lead to the correct diagnosis, which can have major consequences for the treatment and how the patient eventually recovers from the stroke. This also leads to unnecessarily high costs.

Artificial intelligence: fast and precise
The use of artificial intelligence in the treatment of stroke is an important improvement. These algorithms are, by applying the latest computer technology, not only fast, but also precise due to their learning ability. Nico.lab also makes the artificial intelligence solution available via the cloud, allowing hospitals to use it in a low-threshold way. These savings are estimated at over € 200 million on an annual basis, in light of the current costs of € 1.7 billion per year.

Because the computer for this artificial intelligence is not in their own hospital, the scans are encrypted and sent to Nico.lab via an internet connection at lightning speed. After analysis, the specialist receives the notification that he can log in to view the scans and the result itself. It is not important whether the neurologist is in a hospital or in a foreign hotel room while visiting a major medical conference or enjoying a day off at home.

Blockchain technology guarantees patient data confidentiality.
Naturally, confidentiality must be guaranteed when exchanging patient data. Because this is an exchange of privacy-sensitive data in a chain of medical professionals, the use of blockchain technology is the solution. Where many blockchains are known for cryptocurrency such as Bitcoin, the power of blockchain is security in data exchange. Tymlez ensures that all parts in the chain of people and machines are connected to the system via an unbreakable and safe process. The brain scans are then uniquely coded, so that they can only be shared with chain participants who are authorized to do so. The security of patient data is fully guaranteed in this way.

Note for editors:
For more information please contact:
Robert A. Kuipers, CEO Nico.lab: 06 1258 6631.

Nico.lab declares conformity with CE

By | News

Nico.lab declares compliance of its solution StrokeViewer with European medical legislation. By obtaining this CE mark, StrokeViewer is declared safe and secure for stroke patients on the European market.

Nico.lab awarded PPP grant in co-operation with the AMC

By | News

The AMC Amsterdam and Nico.lab have been awarded the Health Holland 2017 PPP allowance for the BRAINS project. The PPP allowance is a Dutch program to provide a financial instrument to help consortia consisting of research organisations, knowledge institutes, companies, and health foundations to realise their innovative ideas.

BRAINS aims at analyzing radiological images to rapidly and reliably assess relevant features. BRAINS wishes to do so by implementing artificial intelligence for analysis of CT and MRI to accurately evaluate two key parameters: collateral capacity and ischemic tissue damage. These applications have the potential to assist adequate and fast treatment decisions, which allows the patient to be treated faster and more efficient, leading to a better outcome.

 

STW Take-off 2 grant awarded to Nico.lab for ANIMATIONS

By | News

We are proud to announce that the Dutch Stichting Technologische Wetenschappen (STW), the national scientific organization focussing on supporting all technology sciences and developments, has awarded Nico.lab 250.000 euros as part of the Take-off program for our proposed ANIMATIONS project. The STW takeoff grant will allow Nico-lab to optimize the ‘operational readiness’ of the algorithms to get from the current Technology Readiness Level (TRL) 7 to TRL9